Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's LillyDirect website.

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

India’s pharmaceutical giants are hoping to earn fat profits as their customers get thinner. With the patent for blockbuster diabetes and weight-loss drugs Ozempic and Wegovy set to expire in March, ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Companies such as Novo Nordisk and Eli Lilly have plans to launch once-daily weight-loss pills in 2026, pending FDA approval, ...

Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong ...

Ozempic and access to generics: a five-year exclusivity clause could delay the arrival of affordable versions in Morocco.

Also effective November 17, Novo Nordisk is lowering the price of Wegovy ® and Ozempic ® for existing self-pay patients in the US from $499 to $349 per month* Self-pay pricing available through ...